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Humans and their gut microbiota have co-evolved over thousands of years, resulting
in the establishment of a complex host–microbiota ecosystem. Early life environmental
factors, such as delivery mode, nutrition, and medication use, have been shown to
substantially affect both host–microbiota interactions and health outcomes. However, the
effects of urbanization (characterized by the spectrum of rural and urban populations) on
these early life events have been overlooked. A deeper understanding of the relationship
between urbanization and microbiota development will allow for the identification of
novel biological and social approaches that can be implemented to prevent and treat
disease and promote maternal and infant/child health. The aim of this narrative review
is to summarize how factors associated with urbanization differentially impact delivery
mode, nutrition, and medication use, and how these changes subsequently affect the
gut microbiota and health outcomes of infants. This narrative review also describes the
important evidence gaps associated with these relationships and recommends actions
that can be taken to improve the health of mothers and infants worldwide.
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INTRODUCTION
Of the many relationships that humans experience in their lifetime, the relationship between
human host and gut microbiota is possibly one of the most important. This relationship has
developed over thousands of years, allowing for the establishment of longstanding and essential
bi-directional host–microbiota interactions. Host–microbiota interactions and functions influence
nutrient metabolism, vitamin synthesis, mucosal maturation, immune-system development, and
biochemical signaling between the gut and the brain (1–4). Accordingly, various human diseases,
including immune-related diseases, chronic metabolic diseases, and neurodevelopmental diseases,
have been associated with disruptions to the gut microbiota composition and function. Combined,
these interactions and associations provide evidence for the important influence of the gut
microbiota on human health outcomes.
One important player in this complex host–microbiota relationship is the external
environment. Multiple, often interrelated, environmental factors influence both the human
gut microbiota and health outcomes. Humans are most susceptible to environmental factors
during early life, and their effects on human health can be evident even in later-life.
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The first 1,000 days of life is a crucial period for the rapid overall
growth and development of a child (5), and it is estimated that
over 1 million new neural connections are formed every second
in the first few years of life (6). In parallel with infant growth and
development, the infant gut microbiota is also being established.
During the first few months of life the infant gut microbiota is
highly dynamic, which is essential for its maturation and for the
stimulation of the immune system. Delivery mode, nutrition, and
medication use are well-studied environmental factors known
to influence the infant gut microbiota and to contribute to
early and later health outcomes (7–10). Other factors, such as
stress and home environment (e.g., number of siblings, pets),
can also play a role (11–13). However, how urbanization may
influence these early life relationships has been overlooked
[Box 1; (16, 17)].
Urban and rural populations can be defined by the different
social structures and associated environmental factors that they
are exposed to. For example urban and rural populations
can differ by demographics, governance, medical interventions,
nutrition, hygiene and sanitation, medication use, and cultural
beliefs (Box 2). Accordingly, these differences could differentially
impact the factors known to shape the infant gut microbiota and
related health outcomes. In fact, research in adult populations
has already demonstrated that urban diets, increased sanitation
and antibiotic exposure contribute to what has been termed
“microbiota insufficiency syndrome” (“the loss of microbial taxa
and associated [microbial] functions that were part of our
evolutionary past”) (4, 18). Adult microbiota composition can
even differ across urbanization gradients within the same country
(19). Combined, these factors have also been associated with
an increase in immune and metabolic diseases in urban adult
populations (4).
The aim of this narrative review is to summarize the
factors associated with urbanization that differentially
impact the well-studied factors of delivery mode, nutrition
and medication use, which in turn impact the infant gut
microbiota and health outcomes in early and later life (Figure 1;
Supplementary Table 1). Next, this narrative review highlights
the most important evidence gaps associated with these well-
studied factors, such as the relationships with malnutrition in all
its forms. This understanding provides insights for the potential
use of biological applications (e.g., modification of the gut
microbiota by diet) and the need for standardization of certain
mother–child health policies across urbanization gradients,
BOX 1 | Urbanization: de nition and its association with income group.
According to the United Nations (UN) Population Division, urbanization can be characterized by the transition from a rural to an urban population. This transition is
associated with “explosive growth of cities, and shifts from an agriculture-based economy to mass industry, technology and services” (14). Based on the 2018
Revision of World Urbanization Prospects (produced by the UN), 55% of the world’s population lives in urban areas. In 2018, regions exhibiting high percentages
of urbanization included Northern America (82%), Latin America and the Caribbean (81%), Europe (74%), and Oceania (68%). Africa, on the other hand, was
considered rural, with only 43% of the population living in urban areas (14). These findings demonstrate the general relationship between urbanization and
geographical location. Urbanization gradients are also closely linked with income-group (as determined by the World Bank) (14, 15). Most high-income countries,
such as Australia, Canada, Japan, the United States of America, and most European countries, exhibit relatively high levels of urbanization (14).
which will contribute to efforts to improve the health outcomes
for mothers and their infants/children worldwide.
DELIVERY MODE, THE GUT MICROBIOTA,
AND HEALTH OUTCOMES
The Effects of Delivery Mode on the Gut
Microbiota and Health Outcomes
An infant’s first encounter with microbes is currently still
debated. While some studies provide evidence for in utero
colonization due to the presence of low abundant microbes in
the placenta and amniotic fluid (20–22), others have argued that
contamination from sampling and DNA extraction kits cannot
be confidently dismissed (23, 24). Regardless, differences between
the gut microbiota of infants born by vaginal delivery or cesarean
section (C-section) are already evident very early in life. Initially,
infants born by vaginal delivery were thought to be exposed
to and colonized by the resident microbes of the lower genital
tract of the mother, with Lactobacillus species being the most
dominant (25, 26). However, two recent studies of the neonate
gut microbiota showed that the prevalence and abundance of
Lactobacillus species were similar in both vaginally delivered and
C-section groups (27, 28). Instead, Bifidobacterium, Escherichia,
Bacteroides, and Parabacteroides species (Table 1) were enriched
in the gut microbiota of vaginally delivered infants, and were
possibly inherited from maternal fecal microbes (27, 28). These
findings complement those from other studies that demonstrated
that maternal gut microbes can be transmitted to infants via
vaginal delivery (35, 36). Transmission and colonization of
the maternal gut microbiota in infants delivered vaginally is
thought to have protective and advantageous functions, as these
microbiota are suited to the environment of the gut and have the
capacity to contribute to nutrient acquisition in early life (28).
In contrast to vaginally delivered infants, infants delivered
by C-section are initially colonized by microbes present in
the delivery environment, in the maternal mouth and on the
maternal skin [Table 1; (3, 7, 8, 25)]. Infants delivered by C-
section have a relatively low initial abundance of Bacteroidetes
(due to inefficient colonization of the gut) and a higher
relative abundance of opportunistic pathogens in comparison
to vaginally delivered infants (27–29). The effects of C-section
delivery on the gut microbiota have been shown to impact
the immune and metabolic development of an infant (7,
37, 38). Indeed, increased childhood immune and metabolic
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BOX 2 | Differences between urban and rural settings.
Demographics Age distribution, annual income, social class, population density, general health (incl. non-communicable diseases, communicable
diseases, co-morbidities, maternal, and infant mortality).
Governance Policies and regulatory systems, services such as education and healthcare (incl. accessibility, availability, and affordability).
Medical interventions Cesarean section delivery rates.
Nutrition Food environments (accessibility, availability, and affordability), industrialized and/or processed foods (incl. antibiotic use in food
production), low fiber/high fat diets, high fiber/low fat diets, etc.
Hygiene and sanitation Access to clean and running water, sewage disposal, plumbing, food, domestic, and public hygiene.
Medication use Antibiotic use (incl. prophylactic antibiotic administration during cesarean section and overuse/misuse of antibiotics), traditional and
complementary medication use, further medication use associated with disease.
Cultural beliefs Westernized and traditional beliefs and practices.
FIGURE 1 | The aim of this narrative review is to describe the relationships between factors associated with urbanization and three well-studied factors—delivery
mode, nutrition, and medication use—known to influence the infant gut microbiota and short- and long-term health outcomes. This figure was created using images
from Servier Medical Art Commons Attribution 3.0 Unported License (http://smart.servier.com). Servier Medical Art by Servier is licensed under a Creative Commons
Attribution 3.0 Unported License.
diseases have been associated with C-section delivery (38).
C-section delivery has also been shown to influence breast milk
composition, as mothers who deliver by elective C-section
do not release hormones usually associated with labor (39,
40). This suggests a possible role for delivery mode in early
life nutrition. Lastly, some infants delivered by C-section are
exposed to antibiotics at birth, depending on placental clamping
procedures used during prophylactic antibiotic administration
(41, 42); the effects of antibiotics on the gut microbiota and
health outcomes of infants are covered in the “Medication
Use, the Gut Microbiota, and Health Outcomes” section of
this review.
The Effects of Urbanization on Delivery
Mode
Although C-section deliveries are an important medical
intervention for high-risk pregnancies globally, they are
generally over-utilized in low risk pregnancies, particularly in
urban and concurrent middle– and high–income countries
[Boxes 1, 2; (43)]. According to a WHO report, in 2008, an
estimated 6.2 million of the C-section deliveries performed
worldwide were unnecessary, with some of the highest C-section
rates belonging to China, Brazil and the USA (44).
Maternal socioeconomic status, healthcare infrastructure (i.e.,
the accessibility, availability, and affordability of high quality
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TABLE 1 | The influence of delivery mode, nutrition, and medication use on the infant gut microbiota.
Factor Source of gut
microbiota
Influence on gut microbiota References
Delivery mode Vaginal delivery Vaginal Canal Higher abundance of Lactobacillus spp. (7, 26)
Maternal Gut Higher abundance of Bifidobacterium longum and B.
breve, Escherichia coli, Bacteroides vulgatus, and
Parabacteroides distasonis
(27, 28)




Delivery environment Low initial abundance of Bacteroidetes and higher
relative abundance of opportunistic pathogens
(27, 29, 30)




Formula milk Gut and environmental
bacteria
Higher abundance of Enterobacteria, Streptococcus,
Bacteroides, and Clostridium, as well as members of the
genus Bifidobacterium
(7, 31)
Medication use Antibiotic use – General decrease in diversity and increase in bacteria
containing antimicrobial resistant genes. Reduction in
Clostridiales, including Lachnospiraceae
(9, 34)
healthcare), type of healthcare facility (i.e., public or private) and
physician practices are all factors associated with urbanization
that contribute to C-section overuse [Figure 2; (45–47)]. In
Brazil, for example the incidence of C-section deliveries was
shown to be 1.6 times higher in private facilities compared to
public facilities, even though maternal preference was for vaginal
delivery (45). Moreover, the effects of physician’s practices on
C-section overuse can be related to several concerns. This can
include lower risks of accusations of malpractice in the event
of C-section delivery complications, or time and infrastructure
concerns, as C-section deliveries can be “scheduled,” thereby
allowing for the time and infrastructure to perform more
deliveries (48).
NUTRITION, THE GUT MICROBIOTA, AND
HEALTH OUTCOMES
The Effects of Nutrition on the Gut
Microbiota and Health Outcomes
Early life nutrition is a well-studied factor that profoundly
impacts the infant gut microbiota and is vital for the overall
growth and development of a child (5, 49, 50). Feeding modes,
such as breastfeeding, formula feeding, mixed feeding, and later
weaning (∼6months) have different effects on the gut microbiota
and on child health outcomes.
Breastfed infants are exposed to various microbial
communities and biological components present on the
mother’s skin and in breast milk [Table 1; (7, 31, 51)]. These
factors are essential for the development of the infant gut
microbiota and immune system. This is mainly because the
biological components present in breast milk include immune
factors (such as antibodies, cytokines, and leukocytes), growth
factors and human milk oligosaccharides (HMOs) (52–54).
HMOs, in particular, are exclusively found in breast milk
and have several beneficial properties. HMOs can: (1) act as
metabolic substrates for the growth of beneficial commensal
gut bacteria (e.g., Bifidobacterium), as HMOs are indigestible
by infants, (2) protect against pathogens and toxins by directly
binding to pathogens or inhibiting binding to host cell receptors,
and (3) contribute to the development of the infant brain
(52, 54, 55). Other breast milk components, such as the hormone
leptin, are involved in infant appetite regulation, and long-chain
polyunsaturated fatty acids facilitate brain development and are
protective against type-2 diabetes (T2D) (56).
In comparison to breast milk, formula milk is generally
higher in protein content, does not contain leptin, and often
does not contain long-chain polyunsaturated fatty acids (56,
57). Some new generation formulas are supplemented with
microbiota such as Bifidobacterium and Lactobacillus species
(58). However, due to a lack of data, these supplementations
show varying effects (58). Regardless, in general, formula-fed
infants show increased gut permeability and bacterial loads,
especially of pro-inflammatory taxa of the gut microbiota
[Table 1; (57)]. In addition, formula-fed infants exhibit adult-
like gut microbiota patterns earlier in life than breastfed
infants (7).
Accordingly, breastfeeding is positively associated with child
health outcomes. In early life, breastfed infants are less
susceptible to infections (such as necrotizing enterocolitis) and
diarrhea (56, 59). Later in life, breastfed infants have lower
adolescent obesity and T2D risks and better cognitive skills
(7, 56, 57, 59–61). In addition, mother–infant bonding during
breastfeeding is considered to positively impact infant cognition
(56). However, early cessation of breastfeeding, either via the
initiation of formula feeding or the premature introduction of
solid foods, has been associated with childhood obesity, and
facilities the transition of the infant gut microbiota toward an
adult-like pattern (5, 7, 62).
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FIGURE 2 | The effects of urbanization on the three well-studied factors, delivery mode, nutrition, and medication use known to influence the infant gut microbiota
and short- and long-term health outcomes. TCM, traditional and complementary medication. This figure was created using images from Servier Medical Art Commons
Attribution 3.0 Unported License (http://smart.servier.com). Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License.
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Although the implications of breastfeeding and formula
feeding have been extensively studied, little information exists
on mixed-feeding practices. While this is surprising considering
that the majority of infants from middle– and high–income
countries are mixed-fed by 3 months of age (57), it is also
expected given that the term “mixed-feeding” is not well-defined.
Mixed feeding could refer to infants who receive a combination
of breast milk and formula milk, or to infants who are initially
exclusively breastfed and then switched to formula milk. Only
by strictly defining the term “mixed-feeding” can we begin to
establish the impacts of early “combined” or “switched” feeding
methods on both the gut microbiota and the health outcomes of
infants (57).
Following breast-, formula-, or mixed-feeding, infants and
children should have adequate access to high quality and diverse
foods for optimal growth and development (59). However,
when maternal and child nutrition is poor, mothers and
their infants can be burdened with malnutrition. Historically,
malnutrition was defined by overweight (including obesity)
and undernutrition (including stunting and wasting), but a
recent series by UNICEF added a third factor termed “hidden
hunger” to this definition (59). Hidden hunger refers to
micronutrient deficiencies (i.e., lack of vitamins and other
essential nutrients) in the diet, which can also contribute to
negative health outcomes (59). The effects of malnutrition on
the gut microbiota and health outcomes of infants, together with
its association to urbanization is described in the “The Effects
of Urbanization on Maternal and Child Malnutrition” section of
this review.
The Effects of Urbanization on Nutrition
The Effects of Urbanization on Breastfeeding
Practices and Behaviors
Nutrition education, cultural beliefs, workforce obligations,
and breastfeeding stigmatization are factors associated
with urbanization that contribute to the early cessation of
breastfeeding, and these factors are differentially observed across
urbanization gradients (Figure 2).
Lack of nutrition education differentially affects mothers
residing in (and raised in) urban and rural communities. In
urban settings, mothers can be inappropriately advised by
maternity hospitals to give supplemental infant formula to their
infants (57). A survey by the CDC, for example concluded that
most hospitals in the USA “do not conform to international
recommendations for best practices in maternity care and
interfere with mothers’ abilities to breastfeed” (63). Across
urbanization gradients, early cessation of breastfeeding can be
associated with lack of nutrition education and cultural beliefs.
In some lessurban Sub-Saharan African countries, for example,
breast milk is believed to be lacking in water. Water, which is
often contaminated in these settings, and solid foods native to
the region are then substituted for breast milk (59, 64). A similar
trend can be observed in countries considered to be more urban.
Chinese immigrant mothers living in Australia, for example,
tend to feed their babies formula milk in the evening, given
the recommendation from their elders that doing so facilitates
breast milk production because of maternal rest (65). In addition,
prior to the recommended weaning age, these mothers also tend
to feed their babies water, honey, and rice porridge under the
assumption that doing so provides the infant with additional
nutrients (65, 66).
Workforce obligations across urbanization gradients
significantly contribute to breastfeeding cessation. While
mothers (and in some cases fathers) from most countries in the
world are entitled to paid parental leave, there are still some
countries, such as the United States, that do not guarantee
paid parental leave (OECD Family Database). Therefore, along
with the effects of an, on average, 18-week period of paid
parental leave (in OECD countries), unpaid parental leave
places an additional pressure on mothers to return to work
early and possibly stop breastfeeding. Indeed, short maternity
leave (<6 weeks) has been shown to negatively affect both
initiation and continuation of breastfeeding (62). Moreover,
regardless of these policies, in rural settings factors such as
poverty, income dependency on work and long working hours
cause mothers to return to work soon after infant delivery,
making it challenging for them to continue breastfeeding
exclusively (59).
Breastfeeding stigmatization also plays a role in
breastfeeding cessation (67). Mothers have expressed the
challenge and stigmatization they experience related to
pumping milk in the work place and in relation to public
breastfeeding, although the latter is less evident in rural
communities (62, 67, 68).
Lastly, it is important to note that numerous other factors
contribute to breastfeeding cessation. These can include infant
fussiness, low infant weight, pre-term birth and maternal
stress and depression (which has also been shown to affect
the gut microbiota and health outcomes of infants); all
of which, to some degree, could also be associated with
urbanization (12, 62).
The Effects of Urbanization on Maternal and Child
Nutrition
Factors associated with urbanization that affect maternal and
child nutrition include food environments (i.e., the accessibility,
availability, and affordability of healthy foods), food practices
(i.e., food preparation and dietary/lifestyle habits), and nutrition
education [Figure 2; (59)]. Maternal and child nutrition further
impacts maternal breast milk, and maternal and infant gut
microbiota, and the health outcomes of infants.
Geographical location is closely linked with urbanization and
the factors associated with it (Boxes 1, 2). Geographical location
has been shown to differentially impact breast milk lipids and
microbiota composition in mothers from Spain, Finland, South
Africa, and China (69). Similarly the breast milk metabolites of
mothers from Australia, Japan, the USA, Norway, and South
Africa have also been shown to differ (70). Breast milk microbiota
composition can also differ across urbanization gradients within
countries. For example the breast milk microbiota of mothers
residing in a rural village in India showed higher microbial
alpha diversity and richness compared to that of Indian mothers
residing in an urban metropolitan city (71). The breast milk
of the rural mothers also had a moderate abundance of
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bacteria belonging to the Firmicutes phyla, while the breast
milk of the urban mothers exhibited a higher abundance
of Proteobacteria (which generally comprise of a variety of
pathogenic bacteria) (71). Accordingly, infants from different
geographical areas across differing urbanization gradients are
exposed to different components in breast milk, which, in
turn, could affect the gut microbiota and health outcomes of
these infants.
Maternal diet during pregnancy, which differs across
urbanization gradient, can also impact the gut microbiota and
health outcomes of infants. Though studies of these relationships
are limited, a recent in vivo mice study has shown that the
maternal gut microbiota, in response to different diets during
pregnancy, can influence the metabolic outcomes of the offspring
(72). This relationship is thought to be mediated by differences
in short chain fatty acid production, which bind to receptors
in the sympathetic nervous system, adipose tissues, pancreas,
and intestine of the embryo (72). Similarly, studies in humans
have also demonstrated a relationship between the maternal diet
during pregnancy and the infant gut microbiota. First, a study
by Lundgren et al. demonstrated that the maternal diet during
pregnancy influenced the infant gut microbiota in a delivery
mode-dependent manner (73). A second study showed that
the maternal diet during pregnancy modulated the maternal
gut microbiota, where maternal carbohydrate and protein
intake was associated with clusters enriched by Prevotella,
and maternal fiber, vegetable, protein, and polyphenol intake
was associated with clusters enriched by Ruminococcus. These
differences were further associated with the initial establishment
of the infant gut microbiota potentially affecting later life
BMI (74).
Urbanization, and the factors associated with it, also
differentially impacts the diets of children, thereby differentially
affecting the gut microbiota and health outcomes of children.
For example the diets of children from a rural village in Burkina
Faso were found to be low in fat and animal protein, but
rich in starch, fiber, and plant polysaccharides, while the diets
of urban Italian children were high in animal protein, sugar,
starch, and fat, but low in fiber (75). When comparing the
gut microbiota of these two groups, the children in Burkina
Faso had a significantly higher abundance of Bacteroidetes,
but a low abundance of Firmicutes, whereas the opposite was
observed for Italian children. Notably, higher ratios of Firmicutes
to Bacteroidetes have been associated with a predisposition
to obesity (76). It has been shown that an urban diet,
especially diets high in fructose and sugar substitutes, can
alter the metabolic capacity of the gut microbiota, thereby
increasing the risk of obesity and obesity-related diseases
[e.g., non-alcoholic fatty liver disease and its more severe
form, non-alcoholic steatohepatitis; reviewed in (77, 78)]. In
contrast, children in Burkina Faso had significantly more
short chain fatty acids than Italian children, and their gut
contained a distinct abundance of bacteria (Prevotella and
Xylanibacter genus) associated with maximizing energy intake
from fibers in response to a polysaccharide-rich diet, thereby
possibly protecting them from inflammation and non-infectious
colonic diseases.
The Effects of Urbanization on Maternal and Child
Malnutrition
Similar to maternal and child nutrition, food environments (i.e.,
the accessibility, availability, and affordability of healthy foods),
food practices (i.e., food preparation and dietary/lifestyle habits)
and nutrition education [Figure 2; (59)] are factors associated
with urbanization that collectively influence maternal and child
malnutrition, and the gut microbiota, and health outcomes of
infants and children.
Unsurprisingly, malnutrition in all its forms varies
across urbanization gradients and associated income groups
(Box 1). For example, overweight is more prevalent in urban
communities, yet it is also on the rise in low– andmiddle–income
countries. As a result, individuals from low– and middle–income
countries, which struggle with undernutrition, experience a
double burden of both overweight and undernutrition (59, 79).
Hidden hunger, on the other hand, is a global issue that has been
associated with different factors. For example hidden hunger
in urban areas is associated with easy access to unhealthy food
options (e.g., nutrient poor, ultra-processed, high fat/sugar
foods), while in rural areas hidden hunger is associated with
the community’s dependence on food security (characterized by
sufficient access to high quality, nutritious, and diverse foods
required to meet recommended dietary needs). Food security
in rural areas can be further threatened by climate and seasonal
changes (59).
Maternal pre-pregnancy overweight increases the risk of
childhood overweight, and has been shown to be mediated by
the combined relationship of C-section delivery and Firmicutes
richness of the infant gut microbiota (80). Maternal overweight
can also differentially impact the gut microbiota and health
outcomes of infants via breast milk composition. For example
breast milk of overweight mothers can differ in comparison to
that of normal weight mothers in two ways. First, breast milk
of overweight mothers can contain lower levels of transforming
growth factor and secretory CD14, which are components
that contribute to infant immune system maturation and are
initially obtained in low amounts during breastfeeding (81).
Second, breast milk of overweight mothers have higher levels of
Staphylococci (skin bacteria) and lower levels of Bifidobacteria,
which are important primary colonizers of the infant gut
(81). These differences have been generally associated with
allergies, inflammatory diseases, and metabolic diseases (81–
83). Moreover, maternal overweight during pregnancy is also a
predictor of childhood obesity and chronic disease, and can be
a risk factor for mothers themselves through increased risks of
gestational diabetes, pre-eclampsia and obstetric complications
(59, 84).
Along with the effects of maternal overweight, childhood
overweight can also impact the gut microbiota and health
outcomes of children. Similar to the effects of maternal
overweight on the breast milk microbiota, the gut microbiota
of overweight children show higher numbers of Staphylococcus
aureus and lower numbers of Bifidobacteria in comparison to
normal weight children (82). Moreover, a study by Payne et al.
(85) showed that the metabolic activity of the gut microbiota of
obese children was increased in comparison to that of normal
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weight children. Several negative short- and long-term health
outcomes have been associated with childhood obesity, including
cardiovascular problems, poor self-esteem, and obesity and
diabetes in later life (59).
Of the few studies that have been performed on the
relationship between maternal undernutrition and the maternal
and infant microbiota, most have been performed in vivo. For
example a mouse study by Connor et al. (86) showed no change
in bacterial composition and richness in the gut microbiota
of caloric-restricted pregnant mice in comparison to healthy
controls. This study, however, was limited by its small sample
size and because dams were killed prior to the delivery of
the pups, which meant that potential changes to breast milk
composition (including, microbiota and biological constituents)
and the transmission of maternal gut microbiota to offspring
could not be studied (86). The importance of this is demonstrated
in a study by Charbonneau et al. (87), which showed that
sialylated HMOs were significantly less abundant in the breast
milk of Malawian mothers of undernourished infants than they
were in mothers of healthy infants. Using two in vivo models
(in mice and piglets), the authors further demonstrated that
offspring’s growth outcomes were improved by adding sialylated
HMOs to their diet (87). These findings are complemented
by studies looking at the effects of seasonality on breast milk
composition and child health outcomes in rural communities. In
the Gambia, for example, an increase in maternal energy intake
during dry seasons (when food is plentiful and disease burden
is low) resulted in significantly increased breast milk HMO
production and was associated with decreased infant morbidity
and improved infant weight- and height-for-age (88). Along with
these outcomes, maternal malnutrition has also been associated
with prenatal complications, preterm birth, low birth weight and
chronic diseases in the later life of the infant (59, 89).
In contrast to maternal undernutrition, the effects of child
undernutrition on the infant gut microbiota and health outcomes
have been well-studied. In general, Proteobacteria (particularly
E. coli) and Streptococcus are increased in the gut microbiota
of undernourished children, while Bacteroidetes and anaerobic
Firmicutes are decreased [reviewed in (90)]. These changes
are associated with the possible inefficient transmission of
health-related maternal gut microbiota. Accordingly, childhood
undernutrition is quite possibly associated with the combined
insult of the presence of highly pathogenic microbes and
microbial deficiency in the guts of undernourished children
(90). The plausibility of this is suggested by studies performed
on children with severe acute malnutrition (SAM) caused
by deficient breastfeeding and food and water insecurity
(90). For example a longitudinal comparative study of the
fecal samples of Malawian twin pairs discordant for SAM
demonstrated that the gut microbiota of the twin with SAM
was immature in comparison with the gut microbiota of
their respective healthy twin control (91). Using gnotobiotic
mice, the authors showed that the gastrointestinal tracts of
mice containing the SAM microbiota were comprised of
higher proportions of Bilophila wadsworthia and Clostridium
innocuum in comparison to healthy controls; species that
have been associated with inflammatory bowel disease and
immune-compromised individuals, respectively (91–95). These
findings suggest that these microbes are possibly associated with
malnourishment on a more global scale.
In another study, children with SAM were provided with
ready-to-use therapeutic food (RUTF; made from peanut paste,
sugar, vegetable oil, and milk fortified with vitamins and
minerals) and administered broad-spectrum oral antimicrobial
agents (96). With this combination, children with SAM
exhibited reduced mortality and improved recovery (94–96).
These findings suggest that the antibiotic treatment may have
targeted potential pathobionts in the gut, thereby facilitating
the colonization of beneficial bacteria in accordance with the
specific diet of the individual. This is further validated by a study
that showed that chronic malnourishment in children (aged 2–5
years) was associated with an overgrowth of oral bacteria in the
gut (97).
Aside from the effects of child malnutrition on the infant
gut microbiota, child malnutrition in general can also impact
the health outcomes of children, and has been associated with
infection, death, and poor outcomes regarding growth, cognition,
school-readiness, school performance, and earning potential in
later life (59).
Given that hidden hunger was only recently described, and
is complex to analyze, the specific effects of maternal and child
hidden hunger on the microbiota and child health outcomes
have not yet been well-studied. It has been noted, however,
that maternal hidden hunger during pregnancy is associated
with maternal morbidity and mortality, neural tube defects and
impaired cognitive development in newborns, preterm births,
and low birth weight (59). Child hidden hunger, on the other
hand, is associated with poor outcomes regarding growth,
development, immunity, tissue development, and health (59).
MEDICATION USE, THE GUT
MICROBIOTA, AND HEALTH OUTCOMES
The Effects of Medication Use on the Gut
Microbiota and Health Outcomes
The effects of medication use on the gut microbiota have been
extensively described in adults. It is known that antibiotics and
some non-antibiotic drugs (such as proton pump inhibitors) can
target the native bacteria of the gut and impair the microbial
ecology of the gut, thereby leaving the gut susceptible to
colonization by extrinsic commensal bacteria (such as microbes
from the mouth) and enteric pathogens (3, 25, 98–100). Changes
to gut microbiota composition due to antibiotic drugs can persist
well after antibiotic administration, though in some cases the gut
microbiota can recover within 1 month (101–103). Medication
use also causes intestinal dysbiosis, which renders the gut
susceptible to infections, dysregulates metabolism, and immune
system homeostasis, and can lead to long-term metabolic effects,
such as obesity (104–107). Moreover, continued exposure to
both antibiotics and some non-antibiotic drugs can increase
the presence of antibiotic-resistant genes in the gut microbiota
(3, 25, 99, 105, 108).
Of the studies that have been performed during prenatal and
early life, most concern the effects of antibiotic use. Maternal
antibiotic use during the prenatal period, for example, has been
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shown to impact both the maternal gut microbiota and the breast
milk microbiota, and is associated with an increased risk of
childhood obesity (109, 110). Similarly, studies performed on the
effects of antibiotics on children demonstrated that antibiotic use
was associated with a less diverse gut microbiota at both the
species- and strain-level, with a reduction in Clostridiales and
an increase in antibiotic-resistant bacteria [Table 1; (9, 34)]. The
negative effects of early life antibiotic use are so evident that
even the positive effects of long breastfeeding duration on the
infant gut microbiota and childhood BMI is reduced by early life
exposure to antibiotics (111).
The Effects of Urbanization on Medication
Use
The Effects of Urbanization on Medical Practices and
Behaviors
Medical practices and behaviors, such as antibiotic overuse or
misuse and traditional and complementary medication use, have
been shown to differ across urbanization gradients and can result
in early life medication exposure. Distal factors associated with
urbanization that impact medical practices and behaviors include
policies and regulatory systems, the medication environment
(i.e., accessibility, availability, and affordability of medications)
and cultural beliefs (Figure 2).
Globally, and across urbanization gradients, only half of
antibiotics are used correctly (112). This, as well as the misuse of
antibiotics, can be attributed to unstandardized, and often poor,
policies, and regulatory systems (41). An example of the latter
is the easy acquisition of antibiotics from local shops or over
the internet without prescription in some geographical locations
(113, 114). Moreover, this relationship can also be observed in
animal husbandry and agriculture (41). In the USA (an urban
and high-income country, Box 1), for example, 80% of the total
annual antimicrobial consumption is attributed to the livestock
sector (112). Given that humans consume livestock, overuse or
misuse of antimicrobials in livestock is also a concern and could
be an additional route of early life exposure to antibiotics (115).
Contrary to popular belief, the use of traditional and
complementary medication (TCM) is also widely common
globally (116). Different factors can contribute to TCM use, but it
often complements conventional medication use in more urban
countries, whereas less urban countries are more dependent on
TCM as a form of primary healthcare (116). The latter is due to
the easier access of TCM and the cultural beliefs/acceptance of
TCM in these regions (116, 117).
While commonly used to treat chronic medications, there is
increasing evidence for the use of maternal TCM (particularly
herbal medicine) during pregnancy, childbirth and postpartum,
including during breastfeeding (117–121). Studies regarding the
effects of TCM use on breast milk components, the breast milk
microbiota, and the gut microbiota are lacking. However, an
article by An et al. (122) reasoned that herbal medications
can affect the gut microbiota in one of two ways. The first
is via metabolism of herbal medication by the gut microbiota.
The second is by regulating the composition and metabolites
of the gut microbiota (122). An example of the latter is that
certain herbal medications can act as probiotics and promote
the growth of beneficial gut microbiota (122). The benefits
and limitations of probiotic use, and its effects on the gut
microbiota, have already been extensively [reviewed in (123)].
Another study, also investigating the effects of herbal medication
on the gut microbiota, showed that some herbal medication
supplementation can promote gut bacteria associated with
positive health outcomes and reduce the relative abundance of
potential pathogens (124). Though the reported outcomes of
some TCM use on the gut microbiota seem promising, it is
important to acknowledge that more research on TCM needs
to be performed, particularly relating to drug–drug interactions
and possible adverse side-effects (116). Given the increased
statistics of TCM use worldwide, and its use during pregnancy,
childbirth, and postpartum (especially during breastfeeding),
more knowledge needs to be obtained about the effects of using
various kinds of TCMon the gut microbiota and health outcomes
of infants.
The Effects of Urbanization on Medication Use
Associated With Maternal and Child Disease
The prevalence of communicable diseases (CDs) and non-
communicable diseases (NCDs) differ across urbanization
gradients and associated income groups (Boxes 1, 2). In 2016, for
example, 50% of all deaths in low-income countries were due to
CDs, nutritional deficiencies and maternal complications during
pregnancy and childbirth, while only 7% of deaths in high-
income countries were due to these causes (125). In contrast, of
the 71% of deaths caused by NCDs, 88% occurred in high-income
countries (125). Along with these statistics, low– and middle–
income countries are experiencing a rise in NCDs, resulting in a
double burden of CDs and NCDs in these countries (5, 59, 125).
Accordingly, the gut microbiota and health outcomes of infants
can be differentially influenced by medication use associated with
maternal and child disease across urbanization gradients.
The effects of NCDs on the gut microbiota (and vice versa)
and their health outcomes have been well-studied (4), while the
effects of CDs have been understudied. This narrative review will
highlight some of the few studies that have been performed on
the effects of maternal and child CDs and associated medication
use on the gut microbiota and health outcomes of infants. As
medication use is closely linked with disease, it can be difficult
to distinguish the effects of medication use and disease on the
gut microbiota.
One example of a maternal medication that is used as a
result of disease is antiretroviral therapy (ART), which is used
to combat HIV. Although HIV has been relatively well-managed
globally, it is still a major health concern in sub-Saharan Africa
[which is considered relatively less urban, Box 1; (126)]. While
there have been studies on the effects of HIV on breast milk
composition [(127); reviewed in (110)], the combined effects of
HIV and ART on the maternal gut microbiota during pregnancy
have been little studied. There is some evidence, however, of the
effects of HIV and ART exposure during pregnancy on the gut
microbiota and health outcomes of infants.
Due to preventative treatment administered to HIV-positive
mothers during pregnancy, per year more than 1 million
infants are born HIV exposed but uninfected with HIV (HEU)
to HIV-positive mothers worldwide. The mortality rates of
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these infants are twice that of infants not exposed to HIV
from the same environment (128–130). In addition to high
mortality rates, HEU infants also experience decreased growth,
differences in metabolism and immune system development, and
increased susceptibility to infections (130–135). Moreover, the
gut microbiota composition of HEU infants differs from that of
infants unexposed to HIV, and the gut bacterial communities
of HEU infants are also less mature—a characteristic generally
observed in HIV-positive individuals (136). As maternal gut
microbes can be transmitted to the infant during delivery, it may
be the impact of HIV and ART on the maternal gut microbiota,
along with changes to the breast milk composition (as mothers
with HIV are still advised to breast feed), that contributes to the
differences observed in HEU babies. Moreover, HEU babies are
placed on prophylactic ART treatment for 4–6 weeks following
birth, and this too could have a major impact on the gut
microbiota and health outcomes of these infants (137). Studies
focused on the effects of ART in general have demonstrated that
ART prevents restoration of gut symbiosis, thereby potentially
facilitating gut dysbiosis (138–143).
Diarrhea is the second leading cause of death in children
under 5 years of age, leading to an estimated 1.5 million deaths
each year (144, 145). The combined insult of diarrhea and
medication use (and often also severe malnutrition) can have
enormous negative effects on the gut microbiota and health
outcome of infants and children (50, 59, 90). For example
the combined treatment of antibiotics and iron fortification
supplements that is generally provided to sub-Saharan African
infants to treat or prevent iron-deficiency anemia can contribute
to childhood diarrheal prevalence (146, 147). Moreover, a small
study by Paganini et al. (147) demonstrated that this combined
treatment resulted in a decreased abundance of Bifidobacterium
(bacteria associated with a healthy gut microbiota) and no
decrease in pathogenic E. coli (one of the bacterial species known
to cause diarrhea) in the infant gut. These findings highlight
the importance of exhibiting caution when providing infants
with antibiotic and iron fortification supplements when they are
suffering from and being treated for diarrheal infections. These
results further indicate the possibility of modulating the gut
microbiota to potentially facilitate positive health outcomes in
the event that there is no other option than to provide combined
treatment. In this case, it would be interesting to determine
whether the addition of Bifidobacterium probiotics (at the strain
level) could improve outcomes with the combined antibiotic and
iron fortification supplementation treatment.
Interestingly, the relationship between the childhood gut
microbiota and infections can also determine the efficacy of
certain childhood medications, and thereby the health outcomes
of infected children. An example of this is the rotavirus vaccine
(RVV), which is used to treat rotavirus infection, one of
the key causes of diarrhea-related deaths. A pilot study by
Harris et al. (148) hypothesized and demonstrated that low
RVV efficacy was correlated with microbiota composition in a
cohort of Pakistani infants. The gut microbiota of infants who
responded to the RVV had an increased relative abundance
of broadly categorized pathogenic bacteria (e.g., Clostridium
cluster XI and Proteobacteria) in comparison to non-responders.
Moreover, higher RVV efficacy was generally observed in a
Dutch infant cohort of RVV-responders, demonstrating higher
RVV efficacy in infants from high-income countries (148).
This could, in part, be explained by differences in breast milk
HMO composition across geographical regions and urbanization
gradients. Indeed, a study by Ramani et al. (149) demonstrated
that a particular geographically distinct neonatal rotavirus strain
in India was increased in an in vitro model in response
to particular HMO constituents. These findings highlight the
importance of understanding how the effects of urbanization
across geographical locations can impact HMO composition and,
as such, influence medication response in children with disease.
FUTURE PERSPECTIVES AND
CONCLUDING REMARKS
This narrative review highlights some of the many factors
associated with urbanization that differentially affect delivery
mode, nutrition, and medication use, which in turn differentially
affect the gut microbiota and health outcomes of infants
across urbanization gradients. We have shown that urbanization
contributes to: C-section overuse in urban communities, poor
infant feeding practices and behaviors across urbanization
gradients, different degrees and forms of malnutrition across
urbanization gradients, and early life medication exposure due
to both medical practices and behaviors, and distinct disease
burdens across urbanization gradients. All of these relationships
have varying effects on the gut microbiota and health outcomes
of infants.
Taking these relationships and their effects into consideration,
we conclude and propose the following:
• The overuse of C-section deliveries, particularly in urban
areas, highlights the need for global, standardized, and ethical
C-section delivery recommendations/guidelines, andmaternal
education on delivery rights. Interventions to optimize C-
section use have been well-reviewed by the “Optimizing
Cesarean Section Use” Lancet series (48).
• Exclusive breastfeeding is highly recommended during early
life due to its clear benefits (150). However, for these
recommendations to be realized, factors associated with
urbanization that contribute to early breastfeeding cessation
or non-exclusive breastfeeding need to be taken into account.
Our narrative review highlights the important need for:
◦ Governmental support for breastfeeding practices
(particularly in public and workplace environments)
to normalize breastfeeding in our societies, to prevent the
negative effects of unpaid and/or little parental leave, and
to encourage mothers, particularly working mothers, to
exclusively breastfeed.
◦ Societal education and awareness about proper exclusive
breastfeeding practices and their benefits (from public to
workforce and healthcare systems).
• The various examples of maternal and child nutrition and
malnutrition in this review highlight the important need to
improve food environments, food practices, and nutrition
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education across urbanization gradients. This has already been
well and extensively reviewed in a recent UNICEF report (59).
Moreover, we showed in this review the important interaction
between diet, the gut microbiota and health outcomes, and
how essential it is to monitor the gut microbiota, for example
to determine the effects of ready-to-use therapeutic foods (and
in some cases antibiotic use) on the gut microbiota and health
outcomes of children with SAM.
• Medical practices and behaviors across urbanization gradients
contribute to early life medication exposure as a result of poor
policies and regulatory systems, medication environments,
and cultural beliefs. This highlights the need to standardize
policies and regulatory systems (for both human and
agricultural medication use), to improve medication
environments (by improving accessibility, availability
and affordability of high-quality, regulated medications)
and to improve our understanding of how cultural beliefs
can contribute to these practices and behaviors. It also
highlights the importance of educating the public of the
effects of medication use and to only use medication if
absolutely necessary.
• Medication use associated with maternal and child disease
differs across urbanization gradients, with a lack of studies
performed on the effects of CDs on the gut microbiota and
health outcomes of infants. CDs and associatedmedication use
not only differentially impact the gut microbiota and health
outcomes of infants and children, but they can also contribute
to reducing medication efficacy. Accordingly, knowledge of
these interactions can facilitate targeted modulation of the
gut microbiota to facilitate positive health outcomes for
infected mothers and children because, more often than not,
medication use associated with disease is required to fight the
disease. Moreover, these findings highlight the importance of
taking these factors into consideration when implementing
applications and policies to improve the health outcomes of
mothers and children with disease.
The factors covered in this narrative review are numerous,
but not exhaustive. Other factors to be considered in future
studies include various genetic, epigenetic, and environmental
factors such as infant sex, parental race/ethnicity, parental
diseases, smoking, pet exposure, stress/depression, pollution,
climate change, marginalized communities (such as refugees),
and cultural practices (such as the Chinese “sitting in period”)
(12, 59, 151). Irrespective, based on the examples provided
in this narrative review, the differential effects of urbanization
on the gut microbiota and health outcomes of infants
are clear.
To further expand our understanding of how the microbiota
impacts health and can be modified to improve health in
a global context, microbiota studies should be continued in
both urban and rural populations, and factors associated with
urbanization that can contribute to maternal and infant health
outcomes should be taken into consideration. By deepening our
understanding of these relationships, and by increasing studies
across urbanization gradients, we can identify and implement
new biological and social approaches to prevent and treat
disease and promote positive maternal and infant/childhood
health world-wide.
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